A summit tackling today’s burning topics in ecosystem leadership and startup programme management.
The Ecosystem Summit provides a platform for ecosystem leaders and startup programme managers to examine the latest global trends and challenges in the entrepreneurial industry. This is an opportunity to examine your current role at each stage of the startup journey and gain a fresh perspective on ecosystem management. The summit is also a global in-person networking opportunity that strengthens the community and facilitates organic connections for future collaborations.
Explore the transformative TRENDS shaping the startup ecosystem.
ACCELERATE your
activity and UPSKILL
your professional
toolbox.
ENGAGE in insightful sessions with influential global industry leaders.
NETWORK with peers steering the startup ecosystems worldwide.
Deep Tech Ecosystems: Talent, Capital & Innovation
Deep tech is captivating the future of startup ecosystems and offering new opportunities for growth at an unforeseen speed. How can you build a sustainable ecosystem for deep tech startups? What are the underlying opportunities in this realm for ecosystem managers? And how can you leverage deep tech startups in your ecosystem and provide them with a nurturing environment? We’ll explore the deep tech ecosystem through talent, capital, and innovation perspectives, discussing how to cultivate the next generation of deep tech talent, fostering collaborations, and nurturing interdisciplinary connections between all ecosystem layers.
Masterclass: Building an Excellent Venture Client Unit
It’s no secret that startups have been the birthplace of revolutionary technologies, from pioneering web browsers to next-generation databases and AI applications like Open AI’s Chat GPT. However, for too long,
incumbent companies have struggled to fully harness the power of startups. Traditional Corporate Venturing models have fallen short of enabling the entire organization to benefit from many top startups quickly and at low cost and risk.
That’s why many corporations are adopting a new model. With a Venture Client Unit, any company can benefit strategically from the world’s best startup technologies at groundbreaking speed and across the entire value chain! But what does it take to establish Venture Client Excellence?
Led by 27pilots, the founders of the Venture Client model.
Innovation Policies: Make or Break?
What pivotal role does innovation policy have in shaping the path of a nation’s innovation ecosystem? How can well-crafted policies serve as powerful enablers? And what are the potential pitfalls of inadequate or poorly designed policies that can act as barriers? With the first wave of AI regulation aiming to provide a safe framework for groundbreaking innovation, explore the future of innovation policies and the potential impact of these on our ecosystems.
The Low-Hanging Fruit – How to Create a Spiral for Your Alumni?
Discover innovative ways to provide value to your alumni, turning them into active participants in your institution’s journey. We’ll discuss leveraging their expertise, fostering a sense of belonging, and offering opportunities for continuous learning and growth. By collaborating with your alumni on multiple occasions, you can amplify your impact and create a dynamic, mutually beneficial relationship.
9:00-10:00
Network and gathering
10:00-10:20
Official opening and welcome remarks
10:20-10:50
From Unicorns to Centaurs – A Shift in Ecosystem Holy Grails
10:50-11:30
Conversations in the VC World – Are We in the Midst of a Power Shift?
11:30 – 12:10
The Ungrateful Startup? A fireside chat
The Complex Relationship Between Startups and Startup Programmes
12:10-12:30
Short Break
12:30 – 13:10 | Main Stage
Open Innovation – Moving to Challenge Based Acceleration for Real Results
12:30 – 13:10 | Breakout Room 2
What makes a successful startup Leader?
The VC perspective
12:30 – 13:10 | Breakout Room 1
Underrepresented Founders and Diversity in our Ecosystem
13:10-14:00
Lunch
14:00 – 14:45 | Main Stage
Money is Just the Beginning – Value Creation for Startups
14:00 – 14:45 | Breakout Room 1
Growing Pains – Taking Your Ecosystem to the Next Maturity Level
14:45 – 15:45 | Main Stage
Future Thinking – How to Predict Trends in a Disruptive Reality
15:45 – 18:00
Happy Hour
Hub Manager
EIT Hub Israel
Director of Ecosystem Strategy
Startup Genome
Managing Partner
Amiti Ventures
Strategic Innovation Consultant & Founder
Woman in Tech Initiative
VP Ecosystem Development
Earth & Beyond Ventures
Innovation Director
Instituto Pedro Nunes
Policy Advisor
European DIGITAL SME Alliance
CEO
81 Unit Alumni Association – AMIT
managing director
EIT MANAFACTURING SOUTH
CEO
27Pilots and partner at deloitte
Head of Solutions
27PILOTS AND Senior manager AT DELOITTE
Head of Policy and Regulation
snpi
manager at Entrepreneurship & Innovation Center
IESE Business School
Head of Public policy israel, innovation policies EMEA
AWS
Head of Artificial intelligence/ machine learning, public policy
AWS
Executive Director
Zell Entrepreneurship Program
Director of Disruptive Ventures The Israeli Innovation Authority
Entrepreneur & Investor
HEAD OF CABINET FOR DRAGOȘ TUDORACHE, MEP
THE EUROPEAN PARLIAMENT
AI & Digital Consultant
Digital Culture
Head of Laboratory of AI & Data Analytics Applications
Tel Aviv University
Entrepreneur & Investor
HEAD OF CABINET FOR DRAGOȘ TUDORACHE, MEP
THE EUROPEAN PARLIAMENT
AI & Digital Consultant
Digital Culture
Head of Policy and Regulation
SNPI
Business Futurist
Fast Forward
Executive-in-Residence
SCHOOLAB San Francisco
Director of Business Development Partnerships
Startup Genome
Chairman
Mind the Bridge
Business Futurist
Fast Forward
Executive-in-Residence
SCHOOLAB San Francisco
Director of Business Development Partnerships
Startup Genome
Executive Director
ASPER-HUJI Innovate
Senior Economics Editor
KAN – Israeli Public Broadcasting Corporation
Partner
TAU Ventures
Managing Partner
91 Ventures
Head of Tech VC Investments European Investment Fund (EIF)
Innovation Manager
Medtronic Integrated Health Solutions
ex-EiR Techstars, ex-MD MassChallenge, EIC Jury Member, Angel Investor, Great River Ventures
Climate tech Investor & Co-founder PLANETech
ENTREPRENEUR, FORMER DIRECTOR OF TECHSTARS ISRAEL, INNOVATION VISIONARY
CEO
8200 Alumni Association
Co-Founder & CEO
Hasoub
Director of Entrepreneurship & Venturing
UM6P
Principal
Verizon Ventures
Senior Startup & VC Business Development Manager, EMEA
Amazon Web Services (AWS)
Global Tech Venturing and Innovation Director
Pepsico
Head of Value Creation
State of Mind Ventures
Principle
UpWest
Regional Innovation Scheme & European Affairs Director
EIT MANUFACTURING HQ
Head of Ecosystem Marketing
Tel Aviv Global & Tourism
VP Value Creation
Glilot Capital
Chair
Global Entrepeneurship Network Israel
Founder & Managing Partner
PerspeXo
CPA, Director of Value Creation
Qumra Capital
Minister Counsellor – Head of Research & Innovation Section
EU Delegation to Israel
The Health not The Death is a fundamental human right. A healthy population is not to be seen as human and social capital, an input, or by-product, towards economic growth. Alongside a healthy and sustainable environment, a solidarity, a healthy population must be the ultimate goal especially nowadays in helping Ukrainian migrants with cancer and their families.
Solidarity in health is a cornerstone of EU health policy. There are wide disparities in many health outcomes across the region and those outcomes. The access rules dramatically affect healthcare systems which are at the forefront of the migrant way, the people who are searching for help and the way how we could enhance and support their healthier and wellbeing status.
In order to ensure their access to care and continued cure in need, the probability of receiving a timely diagnosis and of surviving differs greatly from country to country where they are now. There is lack of information, help and inequalities in access. People need help in navigating cancer knowledge, diagnostics, secondary monitoring and prevention, way of treatments, and care.
Shifting our mindset, supporting healthcare connectivity, removing inequalities overall across Europe is our mission and even more now in a time of crisis, helping the Ukrainian people dealing with cancer is a good place to begin this transformative revolution.
1) Whether we have a chance to foster more holistic and integrated approaches to receive information and care, by supporting coordination and maximising an enabling and health-enhancing effect of care across services from different countries?
2) Whether actions should address the social determinants of health, the countries where they are now, the health need which they have, the social and language barriers are the conditions which have to be taken into consideration in a coordinated manner?
How might we improve patients and /or people who seek healthcare support, access to healthcare services at an EU & the Member States Healthcare systems level? Especially in a time of crisis in Europe.
How might we support refugees fleeing from their countries by navigating them to medical centres to receive best available care?
Precision medicine aims to personalise care for every individual. Nongenomic and genomic determinants, combined with information from patient symptoms, clinical history, and lifestyle (nutrition, physical activity, stress etc.), can facilitate personalised diagnosis and prognostics. Yet this goal requires access to massive amounts of data which may come from different structured and unstructured sources; these can be our medical records, laboratory testing, a range of medical devices as well as from the patient himself. AI & ML can combine input from these multiple sources, analyse them and identify biomarkers that can support health professionals make more informed decisions. The convergence of precision medicine with the advanced AI capabilities will improve the ability to personalise care – improve diagnosis, risk prediction as well as therapy planning.
HCPs want to better predict treatment response, given uncertainty around which treatment to prescribe to which patient and when to prescribe. How do we risk assess the patients, match them with the right treatment (personalised). How can we transform the wealth of data and link it to the predictive nature of how the patient will respond?